FDA approves new ovarian cancer drug

Opening a new chapter in the use of genomic science to fight cancer, the Food & Drug Administration on Friday approved olaparib, a medication for advanced ovarian cancer associated with a defective BRCA gene.



via L.A. Times - Science http://ift.tt/1wvGRaA